Literature DB >> 9006328

In vivo spontaneous neuronal to neuroendocrine lineage conversion in a subset of neuroblastomas.

C Gestblom1, J C Hoehner, F Hedborg, B Sandstedt, S Påhlman.   

Abstract

Neuroblastoma is an embryonal tumor derived from the sympathetic nervous system. Although all neuroblastomas have a neuronal character, a subset of tumors also show evidence of extra-adrenal neuroendocrine differentiation in discrete cell layers. A characterization of the cells of the developing human sympathetic nervous system was performed, identifying growth-associated protein-43, neuropeptide tyrosine, and Bcl-2 as marker genes for sympathetic neurons. Whereas all neuroblastomas express growth-associated protein-43, neuropeptide tyrosine, and Bcl-2, tumors with differentiating cells with neuroendocrine features expressed these genes only in the morphologically immature, proliferating cells. Thus, with neuroendocrine tumor cell differentiation, neuronal marker gene expression vanished and proliferation ceased and was succeeded by expression of chromogranin A/B and insulin-like growth factor-2, markers of neuroendocrine chromaffin differentiation. These tumors appear to provide examples of spontaneous lineage conversion from a neuronal to a neuroendocrine phenotype.

Entities:  

Mesh:

Year:  1997        PMID: 9006328      PMCID: PMC1858509     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  32 in total

1.  Control of enzymatic synthesis of adrenaline in the adrenal medulla by adrenal cortical steroids.

Authors:  R J Wurtman; J Axelrod
Journal:  J Biol Chem       Date:  1966-05-25       Impact factor: 5.157

2.  Developmental potential of quail dorsal root ganglion cells analyzed in vitro and in vivo.

Authors:  H Rohrer; A L Acheson; J Thibault; H Thoenen
Journal:  J Neurosci       Date:  1986-09       Impact factor: 6.167

3.  Nerve growth factor-induced transformation of immature chromaffin cells in vivo into sympathetic neurons: effect of antiserum to nerve growth factor.

Authors:  L Aloe; R Levi-Montalcini
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

Review 4.  Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

Authors:  G M Brodeur; J Pritchard; F Berthold; N L Carlsen; V Castel; R P Castelberry; B De Bernardi; A E Evans; M Favrot; F Hedborg
Journal:  J Clin Oncol       Date:  1993-08       Impact factor: 44.544

5.  Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas.

Authors:  H Shimada; J Chatten; W A Newton; N Sachs; A B Hamoudi; T Chiba; H B Marsden; K Misugi
Journal:  J Natl Cancer Inst       Date:  1984-08       Impact factor: 13.506

6.  Neuropeptide tyrosine (NPY) immunoreactivity in norepinephrine-containing cells and nerves of the mammalian adrenal gland.

Authors:  I M Varndell; J M Polak; J M Allen; G Terenghi; S R Bloom
Journal:  Endocrinology       Date:  1984-04       Impact factor: 4.736

7.  Neuropeptide Y distribution in the rat brain.

Authors:  Y S Allen; T E Adrian; J M Allen; K Tatemoto; T J Crow; S R Bloom; J M Polak
Journal:  Science       Date:  1983-08-26       Impact factor: 47.728

8.  Small intensely fluorescent cells in culture: role of glucocorticoids and growth factors in their development and interconversions with other neural crest derivatives.

Authors:  A J Doupe; P H Patterson; S C Landis
Journal:  J Neurosci       Date:  1985-08       Impact factor: 6.167

9.  Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene.

Authors:  I Garcia; I Martinou; Y Tsujimoto; J C Martinou
Journal:  Science       Date:  1992-10-09       Impact factor: 47.728

10.  Nerve growth factor prevents the death and stimulates the neuronal differentiation of clonal PC12 pheochromocytoma cells in serum-free medium.

Authors:  L A Greene
Journal:  J Cell Biol       Date:  1978-09       Impact factor: 10.539

View more
  9 in total

1.  Up-regulation of insulin-like growth factor-II expression is a feature of TrkA but not TrkB activation in SH-SY5Y neuroblastoma cells.

Authors:  C J Kim; T Matsuo; K H Lee; C J Thiele
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

2.  Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype.

Authors:  Annika Jögi; Ingrid Øra; Helén Nilsson; Asa Lindeheim; Yuichi Makino; Lorenz Poellinger; Håkan Axelson; Sven Påhlman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-14       Impact factor: 11.205

3.  The clinical implications and biologic relevance of neurofilament expression in gastroenteropancreatic neuroendocrine neoplasms.

Authors:  Simon Schimmack; Ben Lawrence; Bernhard Svejda; Daniele Alaimo; Hubertus Schmitz-Winnenthal; Lars Fischer; Markus W Büchler; Mark Kidd; Irvin Modlin
Journal:  Cancer       Date:  2011-10-11       Impact factor: 6.860

4.  Inhibition of angiogenesis induces chromaffin differentiation and apoptosis in neuroblastoma.

Authors:  E Wassberg; F Hedborg; E Sköldenberg; M Stridsberg; R Christofferson
Journal:  Am J Pathol       Date:  1999-02       Impact factor: 4.307

5.  Differentiation in neuroblastoma: diffusion-limited hypoxia induces neuro-endocrine secretory protein 55 and other markers of a chromaffin phenotype.

Authors:  Fredrik Hedborg; Reiner Fischer-Colbrie; Nurtena Ostlin; Bengt Sandstedt; Maxine G B Tran; Patrick H Maxwell
Journal:  PLoS One       Date:  2010-09-17       Impact factor: 3.240

6.  High Myc pathway activity and low stage of neuronal differentiation associate with poor outcome in neuroblastoma.

Authors:  Erik Fredlund; Markus Ringnér; John M Maris; Sven Påhlman
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-09       Impact factor: 11.205

7.  1 alpha-Hydroxyvitamin D2 inhibits growth of human neuroblastoma.

Authors:  Paul R van Ginkel; William Yang; Marcus M Marcet; Clement C Chow; Amol D Kulkarni; Soesiawati Darjatmoko; Mary J Lindstrom; Janice Lokken; Saswati Bhattacharya; Daniel M Albert
Journal:  J Neurooncol       Date:  2007-06-30       Impact factor: 4.130

Review 8.  Cancer cell differentiation heterogeneity and aggressive behavior in solid tumors.

Authors:  Annika Jögi; Marica Vaapil; Martin Johansson; Sven Påhlman
Journal:  Ups J Med Sci       Date:  2012-02-29       Impact factor: 2.384

Review 9.  Hypoxia and hypoxia-inducible factors in neuroblastoma.

Authors:  Sven Påhlman; Sofie Mohlin
Journal:  Cell Tissue Res       Date:  2017-10-14       Impact factor: 5.249

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.